Bernardo Goulart

724 total citations
10 papers, 566 citations indexed

About

Bernardo Goulart is a scholar working on Surgery, Oncology and Otorhinolaryngology. According to data from OpenAlex, Bernardo Goulart has authored 10 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Oncology and 3 papers in Otorhinolaryngology. Recurrent topics in Bernardo Goulart's work include Head and Neck Cancer Studies (3 papers), Thyroid Cancer Diagnosis and Treatment (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Bernardo Goulart is often cited by papers focused on Head and Neck Cancer Studies (3 papers), Thyroid Cancer Diagnosis and Treatment (3 papers) and Pancreatic and Hepatic Oncology Research (2 papers). Bernardo Goulart collaborates with scholars based in United States. Bernardo Goulart's co-authors include Keith D. Eaton, Renato Martins, Peter Capell, David A. Mankoff, Julie E. Bauman, Laurie L. Carr, Laura Q.M. Chow, Christina S. Baik, Rafael Santana-Dávila and Cristina P. Rodriguez and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Bernardo Goulart

10 papers receiving 553 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernardo Goulart United States 8 342 294 109 98 86 10 566
Inês Vieira de Castro Brazil 10 362 1.1× 295 1.0× 190 1.7× 169 1.7× 58 0.7× 15 614
Margarida M. Moura Portugal 10 462 1.4× 215 0.7× 59 0.5× 165 1.7× 171 2.0× 17 593
Eliška Václavíková Czechia 14 492 1.4× 161 0.5× 200 1.8× 143 1.5× 152 1.8× 33 653
André Uchimura Bastos Brazil 12 221 0.6× 105 0.4× 57 0.5× 236 2.4× 86 1.0× 17 494
Justine N. McCutcheon United States 11 110 0.3× 304 1.0× 45 0.4× 204 2.1× 42 0.5× 16 680
Walid Basher Israel 7 118 0.3× 268 0.9× 66 0.6× 85 0.9× 59 0.7× 9 446
Irene Forno Italy 12 220 0.6× 151 0.5× 30 0.3× 277 2.8× 157 1.8× 15 541
Esther O’Regan Ireland 15 74 0.2× 113 0.4× 85 0.8× 151 1.5× 50 0.6× 20 497
Gert Jan Fleuren Netherlands 13 87 0.3× 116 0.4× 64 0.6× 111 1.1× 54 0.6× 16 464
Lianghong Teng China 12 117 0.3× 99 0.3× 46 0.4× 101 1.0× 21 0.2× 32 402

Countries citing papers authored by Bernardo Goulart

Since Specialization
Citations

This map shows the geographic impact of Bernardo Goulart's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernardo Goulart with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernardo Goulart more than expected).

Fields of papers citing papers by Bernardo Goulart

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernardo Goulart. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernardo Goulart. The network helps show where Bernardo Goulart may publish in the future.

Co-authorship network of co-authors of Bernardo Goulart

This figure shows the co-authorship network connecting the top 25 collaborators of Bernardo Goulart. A scholar is included among the top collaborators of Bernardo Goulart based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernardo Goulart. Bernardo Goulart is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Rodriguez, Cristina P., Qian Wu, Jenna Voutsinas, et al.. (2019). A Phase II Trial of Pembrolizumab and Vorinostat in Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland Cancer. Clinical Cancer Research. 26(4). 837–845. 135 indexed citations
2.
Rodriguez, Cristina P., Renato Martins, Christina S. Baik, et al.. (2017). Phase II trial of eribulin mesylate in recurrent or metastatic salivary gland malignancies. Head & Neck. 40(3). 584–589. 11 indexed citations
3.
Pellini, Bruna, Kelsey K. Baker, Mary W. Redman, et al.. (2015). Predictors of outcome in patients with recurrent/metastatic head and neck squamous cell carcinomas (RMHNSCC) treated with weekly cetuximab and paclitaxel (CP).. Journal of Clinical Oncology. 33(15_suppl). e17065–e17065. 1 indexed citations
4.
Yan, Jinchun, Qin Liu, Christina S. Baik, et al.. (2014). Adjuvant Radiotherapy for Stages II and III Resected Thymoma. American Journal of Clinical Oncology. 39(3). 223–227. 11 indexed citations
5.
Chow, Laura Q.M., Keith D. Eaton, Christina S. Baik, et al.. (2014). Phase 1b Trial of TLR8 Agonist VTX-2337 in Combination With Cetuximab in Patients With Recurrent or Metastatic Squamous Cell Carcinomas of the Head and Neck (SCCHN). International Journal of Radiation Oncology*Biology*Physics. 88(2). 503–504. 5 indexed citations
6.
Cheng, Mindy M., Bernardo Goulart, David L. Veenstra, David K. Blough, & Emily Beth Devine. (2012). A network meta-analysis of therapies for previously untreated chronic lymphocytic leukemia. Cancer Treatment Reviews. 38(8). 1004–1011. 12 indexed citations
7.
Carr, Laurie L., David A. Mankoff, Bernardo Goulart, et al.. (2010). Phase II Study of Daily Sunitinib in FDG-PET–Positive, Iodine-Refractory Differentiated Thyroid Cancer and Metastatic Medullary Carcinoma of the Thyroid with Functional Imaging Correlation. Clinical Cancer Research. 16(21). 5260–5268. 324 indexed citations
8.
Goulart, Bernardo, Jeffrey W. Clark, Gregory Y. Lauwers, et al.. (2009). Long term survivors with metastatic pancreatic adenocarcinoma treated with gemcitabine: a retrospective analysis. Journal of Hematology & Oncology. 2(1). 13–13. 21 indexed citations
9.
Goulart, Bernardo, et al.. (2009). Phase II trial of continuous dosing of sunitinib in advanced, FDG-PET avid, medullary thyroid carcinoma (MTC) and well-differentiated thyroid cancer (WDTC). Journal of Clinical Oncology. 27(15_suppl). 6056–6056. 18 indexed citations
10.
Goulart, Bernardo, et al.. (2008). Phase II study of sunitinib in iodine refractory, well-differentiated thyroid cancer (WDTC) and metastatic medullary thyroid carcinoma (MTC). Journal of Clinical Oncology. 26(15_suppl). 6062–6062. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Inês Vieira de Castro Breakdown of academic impact, for papers by Margarida M. Moura Breakdown of academic impact, for papers by Eliška Václavíková Breakdown of academic impact, for papers by André Uchimura Bastos Breakdown of academic impact, for papers by Justine N. McCutcheon Breakdown of academic impact, for papers by Walid Basher Breakdown of academic impact, for papers by Irene Forno Breakdown of academic impact, for papers by Esther O’Regan Breakdown of academic impact, for papers by Gert Jan Fleuren Breakdown of academic impact, for papers by Lianghong Teng
Rankless by CCL
2026